The Valley Desk

NCT01970865 · Interventional trial

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

Overall registry status Completed

Phase 1 · Phase 2

Conditions ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov